DCF — GRANT MEDICAL CENTER
Enterprise Value: $653.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$653.2M
Enterprise Value
$166.6M
PV of Cash Flows
$486.6M
PV of Terminal Value
$783.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.0B | $89.4M | 9.0% | $29.4M | $26.8M |
| Year 2 | $1.1B | $102.8M | 10.0% | $38.4M | $31.7M |
| Year 3 | $1.1B | $117.0M | 11.0% | $47.8M | $35.9M |
| Year 4 | $1.1B | $126.2M | 11.0% | $53.5M | $36.6M |
| Year 5 | $1.2B | $132.9M | 11.0% | $57.3M | $35.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $653.2M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08076146994236105
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5